<PAGE> 1
OMB APPROVAL
OMB 3235-0145
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
------
ZYMETX, INC.
----------------------------------
(Name of Issuer)
Common Stock
----------------------------------
(Title of Class of Securities)
989859 10 3
----------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement /X/. (A
fee is not required only if the filing person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following page(s))
Page 1 of 4 Pages
---
<PAGE> 2
CUSIP No. 989859 10 3 13G Page 2 of 4 Pages
--------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Person. S.S. or I.R.S. Identification Nos. of Above
Person
US Ventech, Inc.
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) /X/
of a Group* (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
British Virgin Islands
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting
Beneficially Power 456,250
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting
Person With Power 0
--------------------------------------------------
(7) Sole Dispositive
Power 456,250
--------------------------------------------------
(8) Shared Dispositive
Power 0
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
456,250
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
7.3%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
CO
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE> 3
SCHEDULE 13G - TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b)
Item 1(a). Name of Issuer:
ZymeTx, Inc.
Item 1(b). Name of Issuer's Principal Executive Offices:
800 Research Parkway, Suite 100
Oklahoma City, OK 73104
Item 2(a). Name of Person Filing:
US Ventech, Inc.
Item 2(b). Address or Principal Business Office or, if None, Residence:
AG Freigustrasse 5
8002 Zurich, Switzerland
Item 2(c). Citizenship:
British Virgin Islands
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
989859 10 3
Item 3. Not applicable.
Item 4. Ownership
(a) Amount Beneficially Owned:
456,50 (*Includes 300,000 shares beneficially owned by Venturetec
Inc. ("Venturetech"), an affiliate of US Ventech, Inc. ("USVI"). USVI
disclaims the beneficial ownership of the shares held by Venturetec
and Venturetech disclaims beneficial ownership of the shares of
Common Stock beneficially owned by USVI. Venturtech and USVI are
investment companies organized under the laws of the British Virgin
Islands. Peter Friedli is the president of both companies and the
principals of both companies are non-U.S. financial institutions.
(b) Percent of Class:
7.3%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
456,250
(ii) shared power to vote or to direct the vote:
0
Page 3 of 4
<PAGE> 4
(iii) sole power to dispose or to direct the disposition of:
456,250
(iv) shared power to dispose or to direct the disposition of:
0
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired in the ordinary course of business
and were not acquired for the purpose of and do not have the effect of changing
or influencing the control of the issuer of such securities and were not
acquired in connection with or as a participant in any transaction having such
purpose or effect.
Signature. After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: December 19, 1997.
US VENTECH, INC.
By: /s/ PETER FRIEDLI
--------------------------------
Signature
Peter Friedli, President
- ----------------------------------
Name/Title
Page 4 of 4
